Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Electromagnetic Technique to Lower Cost of Genome Mapping

By LabMedica International staff writers
Posted on 28 Apr 2009
Researchers have developed a method for the simultaneous sequencing of many DNA chains, an improvement in methodology designed to drastically lower the cost of genome mapping.

Mapping of individual human genomes is hampered by techniques incapable of coping with the more than three billion base pairs that have to be sequenced. More...
To solve this problem and to reduce the cost per patient to $1,000 or less (as requested by the [U.S.] National Institutes for Health), investigators at Brown University (Providence, RI, USA) combined the standard method of electrophoresis, voltage-driven DNA translocation through nanopores, with a novel application of magnetic field technology. The main drawback of the electrophoresis technique has been the high speed at which the DNA molecules move through the site of base pair sequencing, which leads to inaccurate determinations.

The first step in the new technique was to attach DNA strands to 2.8-micron diameter beads using the well-known avidin-biotin binding method. The strands were then placed in an electric field that induced them to move through a gel with nanopores only 10 nm in diameter. While the DNA strands could pass through the pores, the beads could not. Next, a magnetic field was applied in the direction opposite to the electric field, and the strands were slowly pulled back out of the pores. At this time the base pair sequences could be easily and clearly identified. Many individual DNA strands could be handled at the same time.

Senior author Dr. Xinsheng Sean Ling, professor of physics at Brown University said that the investigators called their process "reverse DNA translocation" because, "The DNA is essentially caught in a tug-of-war. And the speed of translocation will be controlled not solely by the electric field but by striking some balance between the magnetic and the electric fields. From there, we can tune it to dictate the speed."

"When it comes to sequencing anyone's genome, you need to do it cheaply, and you need to do it quickly," explained Dr. Ling. "This is a step in that direction."

Related Links:
Brown University


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Portable Electronic Pipette
Mini 96
New
Hemodynamic System Monitor
OptoMonitor
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Cancerguard test is designed to help find multiple cancers in earlier stages to close gaps in cancer screening (Photo courtesy of Exact Sciences)

First-of-Its-Kind Blood Test Detects Over 50 Cancer Types

Many cancers lack routine screening, so patients are often diagnosed only after tumors grow and spread, when options are limited. A faster, less invasive approach that broadens early detection could shift... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.